Nimble Therapeutics
Madison
About Nimble Therapeutics
Nimble Therapeutics is a developer of a drug discovery platform intended to bring the power of massively parallel chemical synthesis to drug discovery. The company uses its unique maskless chemical synthesis platform to synthesize and systematically discover novel medicines in a variety of therapeutic areas, providing customers aid in the empirical optimization of molecules with more favorable drug-like properties.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $10.0M
- Funding stage: M&A
- Last round: Series A (Apr 2019)
- Website: nimbletherapeutics.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Chemical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/nimble-therapeutics-61304 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.